Drug intelligence / Profile preview

糖止方

Development stage: Discontinued
Lead developer: 无权威公司信息（多为传统中医配伍，无特定开发企业）
Administration: Oral

Overview

糖止方是一种中医复方制剂，名称直译为“Sugar-Stopping Formula”，常见于民间或中医药市场，用于辅助降血糖、改善“消渴证”（即现代医学中的2型糖尿病）等症状。该类复合制剂通常以多种中草药配伍组成，常见成分可能包括葛根、黄芪、山药、五味子等，旨在益气养阴、生津止渴。其作用机制主要基于传统中医理论，通过调和脏腑功能、促进胰岛素分泌或改善胰岛素敏感性来达到降血糖的效果，但缺乏现代药理学明确靶点和机制验证[3]。目前未有权威文献显示“糖止方”为已批准的标准化西药或单一活性成分产品。

Brand names: 糖止方
Other names: 糖止方

Beyond the preview

Go deeper on 糖止方.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 糖止方.

Explore the full profile